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A B S T R A C T
Attendance at this year’s European Calciﬁed Tissue Society’s (ECTS) Congress reveals that the methods used to
obtain qPCR results continue to be signiﬁcantly ﬂawed and that and their reporting remain inadequate.
Applications for real-time quantitative PCR (qPCR)-based methods
continue to increase across all areas of the life sciences and have become
routine tools used to evaluate anything from the micro RNA content of
exosomes to preparing cDNA libraries for strand-speciﬁc sequencing. An
important application of reverse transcription (RT)-qPCR is the assessment
of diﬀerential expression patterns characteristic of diseases and infection, as
well as evaluating their prognostic usefulness and using them as an indicator
of treatment eﬃcacy. The most recent meeting of the European Calciﬁed
Tissue Society (ECTS) provided a snapshot of current practices in a
medically important area of biomedical research typiﬁed by the need to
evaluate RNA derived from diﬃcult to obtain tissue and to associate gene
expression signatures with a wide range of conditions that range from
osteoporosis to impaired skeletal muscle function.
Unfortunately, it is clear that despite the publication of the MIQE
guidelines eight years ago [1], the awareness of the need to report
detailed and useful experimental protocols is woefully inadequate. A
survey of participants revealed that whilst 72% and 68% respectively,
of individuals carrying out RT-qPCR experiments thought the technique
was simple and reliable, only 6% were aware of the guidelines
(Table 1). Regrettably, this also applied to those describing themselves
as “expert” users, with a disappointing 13% awareness. Most disheart-
ening was that none of the novice users had heard of the existence of
the guidelines.
This was reﬂected in the additional answers provided, with RNA
integrity and purity rarely assessed and PCR speciﬁcity and eﬃciency
neglected by novice and competent users especially. These results are
conﬁrmed by a survey of ﬁfteen recent publications in this ﬁeld, which
demonstrates quite clearly that there has been little improvement in the
transparency of reporting of qPCR protocols since we published our ﬁrst
evaluation of around 2000 peer-reviewed papers [2] and is consistent
with several surveys carried out since (Table 2).
A surprising issue that continues to dog qPCR-based publications is
that the published primer sequences are often wrong. For example, a
recent publication looking at the impact of dendritic cell interactions
with bone grafts used GAPDH as a reference gene. However, the
published primer sequences for the 19 base pair forward and reverse
primers have two mismatches each with the database reference
sequence (XM_017321385.1) [3]. Furthermore, those primers also
amplify a pseudogene (XM_001476707.5), making their use to quantify
a single reference gene rather unconvincing. The fact that the amplicon
has a secondary structure at the reverse primer binding site is also not
ideal. In addition, primers targeting one of the main genes of interest
amplify both it (bone gamma-carboxyglutamate protein, Bglap
NM_007541.3) as well as two closely related targets (Bglap2
(NM_001032298.3 and Bglap3 NM_001305449.1)).
Most worryingly, qPCR data analysis continues to be confounded by
the near universal use of single, unvalidated reference genes which are
used to calculate ΔΔCq values despite no attempts having been made to
calculate the eﬃciencies of the various qPCR assays. This is despite the
clear directive in the original publication that in order to be valid, the
ampliﬁcation eﬃciencies of the target and reference genes must be
approximately equal and detailed instructions on how to ensure that
this is the case [4]. This would be less of an issue if the reported
diﬀerences in mRNA abundance were huge, but they are typically in the
region of 1.5–8-fold, suggesting that many of the results may be a result
of technical noise. In a certain percentage of papers the results are
meaningless, because not only are single, unvalidated reference genes
used to report expression proﬁles, but published evidence suggests that
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the reference genes themselves are regulated in the conditions under
investigation. For example, GAPDH is widely used as a reference gene
in osteosarcomas, yet it is apparently upregulated at both RNA and
protein levels compared with healthy controls [5].
It is obvious that this situation is not going to improve until journal
editors, in particular, begin taking this egregious, I am tempted to say
scandalous, situation seriously and start to appreciate ﬁrst, that the
majority of peer-reviewed publications utilising qPCR-based methods
are seriously ﬂawed due to inappropriate methods being used and
second, that results are frequently not reproducible due to lack of
relevant information supplied in the Materials and Methods section. It
took 40 years from the ﬁrst report of cell line contamination and
misidentiﬁcation [6] for statements about cell line validation to become
submission prerequisites for most of the major journals. Some, includ-
ing BDQ, require authors to submit detailed information with regards to
their qPCR and digital PCR protocols, but most do not. Let us hope that
it does not take another forty years before this situation is remedied.
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"RT-qPCR is
simple"
38 72% 6 86% 28 74% 4 50%
"RT-qPCR is
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36 68% 6 86% 26 68% 4 50%
Test for Overall % Novice % Competent % Expert %
RNA
integri-
ty
11 21% 1 14% 8 21% 2 25%
RNA purity 2 4% 0 0% 1 3% 1 13%
PCR
speciﬁ-
city
26 49% 0 0% 18 47% 8 100%
PCR
eﬃcien-
cy
18 34% 0 0% 12 32% 6 75%
Awareness
of MIQE
guide-
lines
3 6% 0 0% 2 5% 1 13%
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Analysis of 15 publications selected at random from Pubmed searches using the terms “RT-PCR” and “musculoskeletal” or “osteoporosis” or “bone and hematopoiesis” or “calciﬁed
tissue”.
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[17] no no no no no geNorm 3 not reported yes
[18] no no partial no yes not reported 3 β−Actin, GFAPDH,
LDHA
yes
[19] no no no yes no ΔΔCq 1 β−Actin no
[20] yes (mean RIN = 7.9; range,
7.3–8.7)
no no yes no ΔΔCq 1 β−Actin no
[21] no no partial no no ΔΔCq 1 YWHAZ no
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